Molecular Influenza Diagnostic Market Insights, Global Outlook and Forecast 2022-2028
Molecular Influenza Diagnostic Market Insights, Global Outlook and Forecast 2022-2028
Analysis of the Molecular Influenza Diagnostic Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Molecular assays are a new type of molecular influenza diagnostic test to detect influenza viral RNA or nucleic acids in upper respiratory tract specimens in approximately 15-30 minutes.
The latest research study released by Market IntelliX evaluates market size and forecasts of Molecular Influenza Diagnostic in Global, including the following market information:
Global Molecular Influenza Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Molecular Influenza Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Reverse Transcription Polymerase Chain Reaction (RT-PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Molecular Influenza Diagnostic include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience and BioMerieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Molecular Influenza Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Molecular Influenza Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Molecular Influenza Diagnostic Market Segment Percentages, by Type, 2021 (%)
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Nucleic Acid Sequence Based Amplification (NASBA) Tests
Loop-mediated Isothermal Amplification-Based Assays (LAMP)
Simple Amplification-based Assays (SAMBA)
Global Molecular Influenza Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Molecular Influenza Diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospitals
POCT
Others
Global Molecular Influenza Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Molecular Influenza Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Influenza Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Molecular Influenza Diagnostic revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Molecular Influenza Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Influenza Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Influenza Diagnostic Overall Market Size
2.1 Global Molecular Influenza Diagnostic Market Size: 2021 VS 2028
2.2 Global Molecular Influenza Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Influenza Diagnostic Players in Global Market
3.2 Top Global Molecular Influenza Diagnostic Companies Ranked by Revenue
3.3 Global Molecular Influenza Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Molecular Influenza Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Molecular Influenza Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Influenza Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Molecular Influenza Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Influenza Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Molecular Influenza Diagnostic Market Size Markets, 2021 & 2028
4.1.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
4.1.3 Nucleic Acid Sequence Based Amplification (NASBA) Tests
4.1.4 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
4.1.5 Simple Amplification-based Assays (SAMBA)
4.2 By Type - Global Molecular Influenza Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Molecular Influenza Diagnostic Revenue, 2017-2022
4.2.2 By Type - Global Molecular Influenza Diagnostic Revenue, 2023-2028
4.2.3 By Type - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Influenza Diagnostic Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 POCT
5.1.4 Others
5.2 By Application - Global Molecular Influenza Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Molecular Influenza Diagnostic Revenue, 2017-2022
5.2.2 By Application - Global Molecular Influenza Diagnostic Revenue, 2023-2028
5.2.3 By Application - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Molecular Influenza Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Molecular Influenza Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Molecular Influenza Diagnostic Revenue, 2017-2022
6.2.2 By Region - Global Molecular Influenza Diagnostic Revenue, 2023-2028
6.2.3 By Region - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Molecular Influenza Diagnostic Revenue, 2017-2028
6.3.2 US Molecular Influenza Diagnostic Market Size, 2017-2028
6.3.3 Canada Molecular Influenza Diagnostic Market Size, 2017-2028
6.3.4 Mexico Molecular Influenza Diagnostic Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Molecular Influenza Diagnostic Revenue, 2017-2028
6.4.2 Germany Molecular Influenza Diagnostic Market Size, 2017-2028
6.4.3 France Molecular Influenza Diagnostic Market Size, 2017-2028
6.4.4 U.K. Molecular Influenza Diagnostic Market Size, 2017-2028
6.4.5 Italy Molecular Influenza Diagnostic Market Size, 2017-2028
6.4.6 Russia Molecular Influenza Diagnostic Market Size, 2017-2028
6.4.7 Nordic Countries Molecular Influenza Diagnostic Market Size, 2017-2028
6.4.8 Benelux Molecular Influenza Diagnostic Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Molecular Influenza Diagnostic Revenue, 2017-2028
6.5.2 China Molecular Influenza Diagnostic Market Size, 2017-2028
6.5.3 Japan Molecular Influenza Diagnostic Market Size, 2017-2028
6.5.4 South Korea Molecular Influenza Diagnostic Market Size, 2017-2028
6.5.5 Southeast Asia Molecular Influenza Diagnostic Market Size, 2017-2028
6.5.6 India Molecular Influenza Diagnostic Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Molecular Influenza Diagnostic Revenue, 2017-2028
6.6.2 Brazil Molecular Influenza Diagnostic Market Size, 2017-2028
6.6.3 Argentina Molecular Influenza Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Influenza Diagnostic Revenue, 2017-2028
6.7.2 Turkey Molecular Influenza Diagnostic Market Size, 2017-2028
6.7.3 Israel Molecular Influenza Diagnostic Market Size, 2017-2028
6.7.4 Saudi Arabia Molecular Influenza Diagnostic Market Size, 2017-2028
6.7.5 UAE Molecular Influenza Diagnostic Market Size, 2017-2028
7 Players Profiles
7.1 BD
7.1.1 BD Corporate Summary
7.1.2 BD Business Overview
7.1.3 BD Molecular Influenza Diagnostic Major Product Offerings
7.1.4 BD Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
7.1.5 BD Key News
7.2 Abbott (Include Alere)
7.2.1 Abbott (Include Alere) Corporate Summary
7.2.2 Abbott (Include Alere) Business Overview
7.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Major Product Offerings
7.2.4 Abbott (Include Alere) Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
7.2.5 Abbott (Include Alere) Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Molecular Influenza Diagnostic Major Product Offerings
7.3.4 Roche Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
7.3.5 Roche Key News
7.4 SIEMENS
7.4.1 SIEMENS Corporate Summary
7.4.2 SIEMENS Business Overview
7.4.3 SIEMENS Molecular Influenza Diagnostic Major Product Offerings
7.4.4 SIEMENS Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
7.4.5 SIEMENS Key News
7.5 Analytik Jena
7.5.1 Analytik Jena Corporate Summary
7.5.2 Analytik Jena Business Overview
7.5.3 Analytik Jena Molecular Influenza Diagnostic Major Product Offerings
7.5.4 Analytik Jena Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
7.5.5 Analytik Jena Key News
7.6 Quidel
7.6.1 Quidel Corporate Summary
7.6.2 Quidel Business Overview
7.6.3 Quidel Molecular Influenza Diagnostic Major Product Offerings
7.6.4 Quidel Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
7.6.5 Quidel Key News
7.7 Thermo Fisher
7.7.1 Thermo Fisher Corporate Summary
7.7.2 Thermo Fisher Business Overview
7.7.3 Thermo Fisher Molecular Influenza Diagnostic Major Product Offerings
7.7.4 Thermo Fisher Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
7.7.5 Thermo Fisher Key News
7.8 Meridian Bioscience
7.8.1 Meridian Bioscience Corporate Summary
7.8.2 Meridian Bioscience Business Overview
7.8.3 Meridian Bioscience Molecular Influenza Diagnostic Major Product Offerings
7.8.4 Meridian Bioscience Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
7.8.5 Meridian Bioscience Key News
7.9 BioMerieux
7.9.1 BioMerieux Corporate Summary
7.9.2 BioMerieux Business Overview
7.9.3 BioMerieux Molecular Influenza Diagnostic Major Product Offerings
7.9.4 BioMerieux Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
7.9.5 BioMerieux Key News
7.10 Sekisui Diagnostics
7.10.1 Sekisui Diagnostics Corporate Summary
7.10.2 Sekisui Diagnostics Business Overview
7.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Major Product Offerings
7.10.4 Sekisui Diagnostics Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
7.10.5 Sekisui Diagnostics Key News
7.11 Response Biomedical
7.11.1 Response Biomedical Corporate Summary
7.11.2 Response Biomedical Business Overview
7.11.3 Response Biomedical Molecular Influenza Diagnostic Major Product Offerings
7.11.4 Response Biomedical Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
7.11.5 Response Biomedical Key News
7.12 SA Scientific
7.12.1 SA Scientific Corporate Summary
7.12.2 SA Scientific Business Overview
7.12.3 SA Scientific Molecular Influenza Diagnostic Major Product Offerings
7.12.4 SA Scientific Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
7.12.5 SA Scientific Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Molecular Influenza Diagnostic Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|